Insider Transactions in Q2 2024 at Achieve Life Sciences, Inc. (ACHV)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 19
2024
|
Cindy Jacobs President & CMO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,957
-11.47%
|
$15,828
$4.51 P/Share
|
|
Apr 19
2024
|
Cindy Jacobs President & CMO |
BUY
Exercise of conversion of derivative security
|
Direct |
16,250
+32.01%
|
-
|
|
Apr 19
2024
|
Jerry Wan Principal Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,250
-18.66%
|
$9,000
$4.51 P/Share
|
|
Apr 19
2024
|
Jerry Wan Principal Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,625
+31.81%
|
-
|
|
Apr 19
2024
|
Richard Alistair Stewart Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
10,125
-16.6%
|
$40,500
$4.51 P/Share
|
|
Apr 19
2024
|
Richard Alistair Stewart Executive Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
22,500
+26.95%
|
-
|
|
Apr 19
2024
|
John Bencich CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,088
-5.98%
|
$24,352
$4.51 P/Share
|
|
Apr 19
2024
|
John Bencich CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+19.73%
|
-
|